SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-037075
Filing Date
2018-06-11
Accepted
2018-06-11 18:11:06
Documents
1
Period of Report
2018-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6600
  Complete submission text file 0001209191-18-037075.txt   8236
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
O'Neill Gilmore Neil (Reporting) CIK: 0001742084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14895 | Film No.: 18893108